RELATING TO VALUE-ADDED PRODUCTS.

Sponsors & Cosponsors

Roll Call Votes

Actions Timeline

1. Carried over to 2026 Regular Session.

   12/8/2025

2. Reported from ECD (Stand. Com. Rep. No. 1494) as amended in HD 2, recommending referral to FIN.

   3/21/2025House

3. Report adopted; referred to the committee(s) on FIN as amended in HD 2 with none voting aye with reservations; Representative(s) Pierick voting no (1) and Representative(s) Cochran, Garrett, Kapela, Kitagawa, Ward excused (5).

   3/21/2025House

4. The committee on ECD recommend that the measure be PASSED, WITH AMENDMENTS. The votes were as follows: 7 Ayes: Representative(s) Ilagan, Hussey, Holt, Tam, Templo, Todd, Matsumoto; Ayes with reservations: none; 0 Noes: none; and 0 Excused: none.

   3/19/2025House

5. Reported from AGR (Stand. Com. Rep. No. 1224) as amended in HD 1, recommending passage on Second Reading and referral to ECD.

   3/14/2025House

6. Passed Second Reading as amended in HD 1 and referred to the committee(s) on ECD with none voting aye with reservations; none voting no (0) and Representative(s) Cochran, Holt, Iwamoto, Ward excused (4).

   3/14/2025House

7. Bill scheduled to be heard by ECD on Wednesday, 03-19-25 10:00AM in House conference room 423 VIA VIDEOCONFERENCE.

   3/14/2025House

8. The committee on AGR recommend that the measure be PASSED, WITH AMENDMENTS. The votes were as follows: 5 Ayes: Representative(s) Kahaloa, Kusch, Lowen, Perruso, Quinlan; Ayes with reservations: none; 0 Noes: none; and 1 Excused: Representative(s) Ward.

   3/12/2025House

9. Bill scheduled to be heard by AGR on Wednesday, 03-12-25 9:00AM in House conference room 325 VIA VIDEOCONFERENCE.

   3/7/2025House

10. Pass First Reading

    3/6/2025House

11. Referred to AGR, ECD, FIN, referral sheet 19

    3/6/2025House

12. Report adopted; Passed Third Reading, as amended (SD 2). Ayes, 25; Aye(s) with reservations: none . Noes, 0 (none). Excused, 0 (none). Transmitted to House.

    3/4/2025Senate

13. Received from Senate (Sen. Com. No. 167) in amended form (SD 2).

    3/4/2025House

14. Reported from WAM (Stand. Com. Rep. No. 759) with recommendation of passage on Third Reading, as amended (SD 2).

    2/27/2025Senate

15. 48 Hrs. Notice 03-04-25.

    2/27/2025Senate

16. The committee(s) on WAM recommend(s) that the measure be PASSED, WITH AMENDMENTS. The votes in WAM were as follows: 12 Aye(s): Senator(s) Dela Cruz, Moriwaki, Aquino, Elefante, Hashimoto, Inouye, Kanuha, Kidani, Kim, Lee, C., Wakai, Fevella; Aye(s) with reservations: none ; 0 No(es): none; and 1 Excused: Senator(s) DeCoite.

    2/18/2025Senate

17. The committee(s) on WAM will hold a public decision making on 02-18-25 10:01AM; Conference Room 211 & Videoconference.

    2/14/2025Senate

18. Reported from EDT/AEN (Stand. Com. Rep. No. 464) with recommendation of passage on Second Reading, as amended (SD 1) and referral to WAM.

    2/13/2025Senate

19. Report adopted; Passed Second Reading, as amended (SD 1) and referred to WAM.

    2/13/2025Senate

20. The committee(s) on EDT recommend(s) that the measure be PASSED, WITH AMENDMENTS. The votes in EDT were as follows: 5 Aye(s): Senator(s) DeCoite, Wakai, Fukunaga, Kim, Awa; Aye(s) with reservations: none ; 0 No(es): none; and 0 Excused: none.

    2/11/2025Senate

21. The committee(s) on AEN recommend(s) that the measure be PASSED, WITH AMENDMENTS. The votes in AEN were as follows: 4 Aye(s): Senator(s) Gabbard, DeCoite, Rhoads, Awa; Aye(s) with reservations: none ; 0 No(es): none; and 1 Excused: Senator(s) Richards.

    2/11/2025Senate

22. The committee(s) on EDT/AEN has scheduled a public hearing on 02-11-25 1:01PM; Conference Room 229 & Videoconference.

    2/7/2025Senate

23. Referred to EDT/AEN, WAM.

    1/21/2025Senate

24. Introduced.

    1/17/2025Senate

25. Passed First Reading.

    1/17/2025Senate

Bill Text

• Bill Text

  PDF

• Original

  HTMLPDF

• SB558_HD1

  HTML

• SB558_HD2

  HTML

• SB558_SD1

  HTML

• SB558_SD2

  HTML